4 Analysts Assess AngioDynamics: What You Need To Know
Portfolio Pulse from Benzinga Insights
Four analysts have evaluated AngioDynamics (NASDAQ:ANGO) over the past three months, with a mix of bullish and bearish opinions. The average 12-month price target is $13.25, a 10.17% decline from the previous target. Analysts have adjusted their ratings and price targets in response to market conditions. AngioDynamics faces financial challenges, including a 22.06% revenue decline, but maintains strong net margins and effective debt management.
October 04, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
AngioDynamics has received mixed analyst ratings, with a recent average price target of $13.25, down 10.17% from prior estimates. The company faces a 22.06% revenue decline but maintains strong net margins and effective debt management.
The mixed analyst ratings and reduced price target suggest uncertainty in the short-term outlook for AngioDynamics. The company's financial challenges, including a significant revenue decline, are concerning. However, strong net margins and effective debt management provide some stability, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100